Orbitofrontal response to drug-related stimuli after heroin administration

Addiction Biology

Volumn 20, Issue 3, 2015, Pages 570-579

  Walter, Marc ^a   Denier, Niklaus ^a   Gerber, Hana ^a   Schmid, Otto ^a   Lanz, Christian ^b   Brenneisen, Rudolf ^b   Riecher Rössler, Anita ^a   Wiesbeck, Gerhard A ^a   Scheffler, Klaus ^c,d,e   Seifritz, Erich ^f   McGuire, Philip ^g   Fusar Poli, Paolo ^g   Borgwardt, Stefan ^a,g,h  

^a UNIVERSITY OF BASEL   (Switzerland)

^b UNIVERSITY OF BERN   (Switzerland)

^c Department of Obstetrics and Gynaecology   (Switzerland)

^d MAX PLANCK INSTITUTE FOR BIOLOGICAL CYBERNETICS   (Germany)

^e UNIVERSITY OF TÜBINGEN   (Germany)

^f Psychiatric University   (Switzerland)

^g KING'S COLLEGE LONDON   (United Kingdom)

^h UNIVERSITY HOSPITAL BASEL   (Switzerland)

Author keywords

Addiction; functional magnetic resonance imaging (fMRI); heroin dependence; opioids

Indexed keywords

6 MONACETYLMORPHINE; DIAMORPHINE; DRUG METABOLITE; MORPHINE; PLACEBO; UNCLASSIFIED DRUG; NARCOTIC AGENT;

ADULT; ARTICLE; ASSOCIATION; BOLD SIGNAL; BRAIN FUNCTION; CLINICAL ARTICLE; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; DRUG BLOOD LEVEL; FEMALE; FUNCTIONAL MAGNETIC RESONANCE IMAGING; GRAY MATTER; HEROIN DEPENDENCE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; IMAGE ANALYSIS; MALE; ORBITAL CORTEX; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; BRAIN DISEASE; DRUG EFFECTS; NEUROPSYCHOLOGICAL TEST; NUCLEAR MAGNETIC RESONANCE IMAGING; ORGAN SIZE; PATHOLOGY; PATHOPHYSIOLOGY; PREFRONTAL CORTEX; WITHDRAWAL SYNDROME;

ADULT; BRAIN DISEASES; CRAVING; CUES; FEMALE; GRAY MATTER; HEROIN; HEROIN DEPENDENCE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; NARCOTICS; NEUROPSYCHOLOGICAL TESTS; ORGAN SIZE; PREFRONTAL CORTEX;

EID: 84926522620     PISSN: 13556215     EISSN: 13691600     Source Type: Journal    
DOI: 10.1111/adb.12145     Document Type: Article

References (43)

1. Blanken P, Hendriks VM, Koeter MW, van Ree JM, van den Brink W, (2012) Craving and illicit heroin use among patients in heroin-assisted treatment. Drug Alcohol Depend 120: 74-80.
2. Bourquin D, Bundeli P, Lehmann T, Brenneisen R, (1999) Diacetylmorphine and its metabolites in plasma by HPLC with diode-array and atmospheric pressure ionization mass spectrometric detection. J Liq Chromatogr Rel Technol 22: 2663-2674.
3. Bühler M, Mann K, (2011) Alcohol and the human brain: a systematic review of different neuroimaging methods. Alcohol Clin Exp Res 35: 1771-1793.
4. Cami J, Farré M, (2003) Drug addiction. N Engl J Med 349: 975-986.
5. Denier N, Gerber H, Vogel M, Klarhöfer M, Riecher-Rossler A, Wiesbeck GA, Lang UE, Borgwardt S, Walter M, (2013) Reduction in cerebral perfusion after heroin administration: a resting state arterial spin labeling study. PLoS ONE 8: e71461.
6. Gerber H, Borgwardt SJ, Schmid O, Gerhard U, Joechle W, Riecher-Rössler A, Wiesbeck GA, Walter M, (2012) The impact of diacetylmorphine on hypothalamic-pituitary-adrenal axis activity and heroin craving in heroin dependence. Eur Addict Res 18: 116-123.
7. Goldstein RZ, Volkow ND, (2002) Drug addiction and its underlying neurobiological basis: neuroimaging evidence for the involvement of the frontal cortex. Am J Psychiatry 159: 1642-1652.
8. Haasen C, Verthein U, Degkwitz P, Berger J, Krausz M, Naber D, (2007) Heroin-assisted treatment for opioid dependence: randomised controlled trial. Br J Psychiatry 191: 55-62.
9. Hayasaka S, Phan KL, Liberzon I, Worsley KJ, Nichols TE, (2004) Nonstationary cluster-size inference with random field and permutation methods. Neuroimage 22: 676-687.
10. Koob GF, Volkow ND, (2010) Neurocircuitry of addiction. Neuropsychopharmacology 35: 217-238.
11. Kringelbach ML, (2005) The human orbitofrontal cortex: linking reward to hedonic experience. Nat Rev Neurosci 6: 691-702.
12. Krupitsky E, Nunes EV, Ling W, Gastfriend DR, Memisoglu A, Silverman BL, (2013) Injectable extended-release naltrexone (XR-NTX) for opioid dependence: long-term safety and effectiveness. Addiction 108: 1628-1637.
13. Lang PJ, Bradley MM, Cuthbert BN, (1997) International Affective Picture System (IAPS): Technical Manual and Affective Ratings. Gainesville, FL: University of Florida.
14. Langleben DD, Ruparel K, Elman I, Busch-Winokur S, Pratiwadi R, Loughead J, O'Brien CP, Childress AR, (2008) Acute effect of methadone maintenance dose on brain fMRI response to heroin-related cues. Am J Psychiatry 165: 390-394.
15. Langleben DD, Ruparel K, Elman I, Loughead JW, Busch EL, Cornish J, Lynch KG, Nuwayser ES, Childress AR, O'Brien CP, (2014) Extended-release naltrexone modulates brain response to drug cues in abstinent heroin-dependent patients. Addict Biol 19: 262-271.
16. Leshner AI, (1997) Addiction is a brain disease, and it matters. Science 278: 45-47.
17. Li Q, Wang Y, Zhang Y, Li W, Yang W, Zhu J, Wu N, Chang H, Zheng Y, Qin W, Zhao L, Yuan K, Liu J, Wang W, Tian J, (2012) Craving correlates with mesolimbic responses to heroin-related cues in short-term abstinence from heroin: an event-related fMRI study. Brain Res 1469: 63-72.
18. Liu H, Hao Y, Kaneko Y, Ouyang X, Zhang Y, Xu L, Xue Z, Liu Z, (2009) Frontal and cingulate gray matter volume reduction in heroin dependence: optimized voxel-based morphometry. Psychiatry Clin Neurosci 63: 563-568.
19. Lucantonio F, Stalnaker TA, Shaham Y, Niv Y, Schoenbaum G, (2012) The impact of orbitofrontal dysfunction on cocaine addiction. Nat Neurosci 15: 358-366.
20. Lyoo IK, Pollack MH, Silveri MM, Ahn KH, Diaz CI, Hwang J, Kim SJ, Yurgelun-Todd DA, Kaufman MJ, Renshaw PF, (2006) Prefrontal and temporal gray matter density decreases in opiate dependence. Psychopharmacology (Berl) 184: 139-144.
21. Mei W, Zhang JX, Xiao Z, (2010) Acute effects of sublingual buprenorphine on brain responses to heroin-related cues in early-abstinent heroin addicts: an uncontrolled trial. Neuroscience 170: 808-815.
22. Oviedo-Joekes E, Brissette S, Marsh DC, Lauzon P, Guh D, Anis A, Schechter MT, (2009) Diacetylmorphine versus methadone for the treatment of opioid addiction. N Engl J Med 361: 777-786.
23. Petersson KM, Nichols TE, Poline JB, Holmes AP, (1999) Statistical limitations in functional neuroimaging. II. Signal detection and statistical inference. Philos Trans R Soc Lond B Biol Sci 354: 1261-1281.
24. Petrovic P, Kalso E, Petersson KM, Ingvar M, (2002) Placebo and opioid analgesia-imaging a shared neuronal network. Science 295: 1737-1740.
25. Pfeiffer A, Pasi A, Mehraein P, Herz A, (1982) Opiate receptor binding sites in human brain. Brain Res 248: 87-96.
26. Qiu YW, Jiang GH, Su HH, Lv XF, Tian JZ, Li LM, Zhuo FZ, (2013) The impulsivity behavior is correlated with prefrontal cortex gray matter volume reduction in heroin-dependent individuals. Neurosci Lett 538: 43-48.
27. Schmidt A, Walter M, Gerber H, Schmid O, Smieskova R, Bendfeldt K, Wiesbeck GA, Riecher-Rössler A, Lang UE, Rubia K, McGuire P, Borgwardt S, (2013) Inferior frontal cortex modulation with an acute dose of heroin during cognitive control. Neuropsychopharmacology 38: 2231-2239.
28. Schoenbaum G, Shaham Y, (2008) The role of orbitofrontal cortex in drug addiction: a review of preclinical studies. Biol Psychiatry 63: 256-262.
29. Schoenbaum G, Roesch MR, Stalnaker TA, (2006) Orbitofrontal cortex, decision-making and drug addiction. Trends Neurosci 29: 116-124.
30. Shaham Y, Shalev U, Lu L, De Wit H, Stewart J, (2003) The reinstatement model of drug relapse: history, methodology and major findings. Psychopharmacology (Berl) 168: 3-20.
31. Strain EC, Stitzer ML, (2006) The Treatment of Opioid Dependence. Baltimore, MD: John Hopkins University Press.
32. Tiffany ST, (1999) Cognitive concepts of craving. Alcohol Res Health 23: 215-224.
33. Tiffany ST, Carter BL, (1998) Is craving the source of compulsive drug use? J Psychopharmacol 12: 23-30.
34. Van den Brink W, Hendricks VM, Blanken P, Koeter MWJ, van Zwieten BJ, van Ree JM, (2003) Medical prescription of heroin to treatment resistant heroin addicts: two randomised controlled trials. BMJ 327: 310-312.
35. Volkow ND, Fowler JS, (2000) Addiction, a disease of compulsion and drive: involvement of the orbitofrontal cortex. Cereb Cortex 10: 318-325.
36. Volkow ND, Fowler JS, Wang GJ, (2003) The addicted human brain: insights from imaging studies. J Clin Invest 111: 1444-1451.
37. Walter M, Wiesbeck GA, Bloch N, Aeschbach S, Olbrich HM, Seifritz E, Dürsteler-MacFarland KM, (2008) Psychobiological responses to drug cues before and after methadone intake in heroin-dependent patients: a pilot study. Eur Neuropsychopharmacol 18: 390-393.
38. Walter M, Wiesbeck GA, Degen B, Albrich J, Oppel M, Schulz A, Schächinger H, Dürsteler-MacFarland KM, (2011) Heroin reduces startle and cortisol response in opioid-maintained heroin-dependent patients. Addict Biol 16: 145-151.
39. Walter M, Gerber H, Kuhl HC, Schmid O, Joechle W, Lanz C, Brenneisen R, Schächinger H, Riecher-Rössler A, Wiesbeck GA, Borgwardt SJ, (2013) Acute effects of intravenous diacetylmorphine on the hypothalamic-pituitary-adrenal axis response. J Clin Psychopharmacol 33: 193-198.
40. Wang X, Li B, Zhou X, Liao Y, Tang J, Liu T, Hu D, Hao W, (2012) Changes in brain gray matter in abstinent heroin addicts. Drug Alcohol Depend 126: 304-308.
41. Xiao Z, Lee T, Zhang JX, Wu Q, Wu R, Weng X, Hu X, (2006) Thirsty heroin addicts show different fMRI activations when exposed to water-related and drug-related cues. Drug Alcohol Depend 83: 157-162.
42. Yang Z, Xie J, Shao YC, Xie CM, Fu LP, Li DJ, Fan M, Ma L, Li SJ, (2009) Dynamic neural responses to cue-reactivity paradigms in heroin-dependent users: an fMRI study. Hum Brain Mapp 30: 766-775.
43. Yuan Y, Zhu Z, Shi J, Zou Z, Yuan F, Liu Y, Lee TM, Weng X, (2009) Gray matter density negatively correlates with duration of heroin use in young lifetime heroin-dependent individuals. Brain Cogn 71: 223-228.